Effects of ABT‐229, a motilin agonist, on acid reflux, oesophageal motility and gastric emptying in patients with gastro‐oesophageal reflux disease

Peter Netzer, Brenda Landvoigt Schmitt, W. Inauen

Alimentary Pharmacology & Therapeutics · 2002 · 29 citations · 41 references

DOIFull text

Open access

Abstract

ABT-229 is able to reduce slightly, but significantly, acid reflux in patients with gastro-oesophageal reflux disease. This effect does not appear to be due to a measurable improvement in oesophageal motility or gastric emptying.

References

41